124 related articles for article (PubMed ID: 38820837)
1. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
Lucio-Gutiérrez JR; Cordero-Pérez P; Ávila-Velázquez JL; Torres-González L; Farías-Navarro IC; Govea-Torres G; Sánchez-Martínez C; García-Hernández PA; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Waksman-Minsky NH; Saucedo AL
J Pharm Biomed Anal; 2024 Sep; 247():116240. PubMed ID: 38820837
[TBL] [Abstract][Full Text] [Related]
2. Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes.
Lucio-Gutiérrez JR; Cordero-Pérez P; Farías-Navarro IC; Tijerina-Marquez R; Sánchez-Martínez C; Ávila-Velázquez JL; García-Hernández PA; Náñez-Terreros H; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Torres-González L; Waksman-Minsky NH; Saucedo AL
J Pharm Biomed Anal; 2022 Sep; 219():114885. PubMed ID: 35779355
[TBL] [Abstract][Full Text] [Related]
3. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
[TBL] [Abstract][Full Text] [Related]
4. Altered amino acid metabolism between coronary heart disease patients with and without type 2 diabetes by quantitative
Zhang L; Zhang Y; Ma Z; Zhu Y; Chen Z
J Pharm Biomed Anal; 2021 Nov; 206():114381. PubMed ID: 34583124
[TBL] [Abstract][Full Text] [Related]
5. Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.
Zhang F; Guo R; Cui W; Wang L; Xiao J; Shang J; Zhao Z
Ren Fail; 2021 Dec; 43(1):980-992. PubMed ID: 34157945
[TBL] [Abstract][Full Text] [Related]
6. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.
Mika A; Wojtowicz W; Ząbek A; Młynarz P; Chmielewski M; Sledzinski T; Stepnowski P
J Pharm Biomed Anal; 2018 Feb; 149():1-8. PubMed ID: 29100025
[TBL] [Abstract][Full Text] [Related]
7. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
[TBL] [Abstract][Full Text] [Related]
8. Interpretable machine learning identifies metabolites associated with glomerular filtration rate in type 2 diabetes patients.
An TF; Zhang ZP; Xue JT; Luo WM; Li Y; Fang ZZ; Zong GW
Front Endocrinol (Lausanne); 2024; 15():1279034. PubMed ID: 38915893
[TBL] [Abstract][Full Text] [Related]
9. Untargeted plasma
Fonseca RID; Menezes LRA; Santana-Filho AP; Schiefer EM; Pecoits-Filho R; Stinghen AEM; Sassaki GL
J Pharm Biomed Anal; 2023 May; 229():115339. PubMed ID: 36963247
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
[TBL] [Abstract][Full Text] [Related]
11. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators.
Cordero-Pérez P; Sánchez-Martínez C; García-Hernández PA; Saucedo AL
Nefrologia (Engl Ed); 2020; 40(6):585-596. PubMed ID: 33036786
[TBL] [Abstract][Full Text] [Related]
13. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
14. Plasma biomarker discovery for early chronic kidney disease diagnosis based on chemometric approaches using LC-QTOF targeted metabolomics data.
Benito S; Sánchez-Ortega A; Unceta N; Jansen JJ; Postma G; Andrade F; Aldámiz-Echevarria L; Buydens LMC; Goicolea MA; Barrio RJ
J Pharm Biomed Anal; 2018 Feb; 149():46-56. PubMed ID: 29100030
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
[TBL] [Abstract][Full Text] [Related]
16. Screening of Altered Metabolites and Metabolic Pathways in Celiac Disease Using NMR Spectroscopy.
Khalkhal E; Rezaei-Tavirani M; Fathi F; Nobakht M Gh BF; Taherkhani A; Rostami-Nejad M; Asri N; Haidari MH
Biomed Res Int; 2021; 2021():1798783. PubMed ID: 34820452
[TBL] [Abstract][Full Text] [Related]
17. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
18. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
[TBL] [Abstract][Full Text] [Related]
19. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
